drugset / Trial / NCT02768389
Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
Phase 0
Completed
18 enrolled
Case Comprehensive Cancer Center
OhioHealth Research Institute · collabUniversity of Cincinnati · collab
NaSingle-groupOpen-labelTreatment
Summary
Patients may participate in this research study if they have glioblastoma. (a brain tumor) that has come back after being treated. Standard treatment for this cancer is a chemotherapy drug called bevacizumab. This research study involves bevacizumab in combination with a special diet called the Modified Atkins Diet (MAD). The purpose of this study is to research if patients can stay on the MAD when it is added to the standard bevacizumab treatment.
Timeline
- Start
- 2016-09-06
- Primary completion
- 2018-11
- Completion
- 2018-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bevacizumab | Monoclonal antibody | — | — |